Comparison of antibody levels for four different immunization schedules for PCVs
The use of 4 different 13-valent pneumococcal conjugate vaccine immunization schedules in healthy term infants resulted in no statistically significant differences in antibody levels between the...
View ArticleVaccine against pneumococcal infections has led to widespread reduction in...
Vaccination with the pneumococcal conjugate vaccine-7 [PCV7—a vaccine that covers 7 strains (serotypes) of Streptococcus pneumoniae] is linked to overall decreases in the rate of serious infections...
View ArticlePneumococcal disease, whooping cough, campylobacteriosis most common...
The population is ageing. Data of notifiable infectious diseases among those aged 65 years and older have been analysed by the Norwegian Institute of Public Health. The results show that invasive...
View ArticleStudy finds Pfizer vaccine cuts pneumonia in elderly
Pfizer Inc. said Wednesday that its blockbuster vaccine against pneumonia, blood and other infections met its goal of preventing illness in vulnerable elderly patients in a huge study required by U.S....
View ArticleFresh hope for preventing pneumonia in the elderly
There are calls for the frail and elderly not be be overlooked for vaccines against pneumonia this winter, with UNSW research challenging conventional wisdom on immunisation effectiveness in older...
View ArticleVaccination isn't just for kids – a guide for over-65s
We live in an ageing society, with the global median age rising steadily. Australia's economic viability will increasingly rely on retaining older people in the workforce for longer. This, of course,...
View ArticleHow pneumonia bacteria can compromise heart health
Bacterial pneumonia in adults carries an elevated risk for adverse cardiac events (such as heart failure, arrhythmias, and heart attacks) that contribute substantially to mortality—but how the heart is...
View ArticlePneumococcal vaccine reduces antibiotic-resistant infections in children by...
The pneumococcal vaccine recommended for young children not only prevents illness and death, but also has dramatically reduced severe antibiotic-resistant infections, suggests nationwide research being...
View ArticleStudy shows vaccination leads to decline in pneumococcal disease and...
Wits University and the National Institute for Communicable Diseases (NICD) released a new study, led by Wits academics, showing rates of invasive pneumococcal disease (IPD) - including cases caused by...
View ArticlePCV13 recommended for 6- to 18-year-olds at high risk
(HealthDay)—Pneumococcal conjugate vaccine 13 (PCV13) should be administered to certain children aged 6 through 18 years who are at high risk of invasive pneumococcal disease (IPD), according to a...
View ArticleSeniors need two pneumonia vaccines, CDC advisory panel says
(HealthDay)—Adults 65 and older need two vaccines to better protect them from bacterial infection in the blood (called sepsis), meningitis and pneumonia, according to a revised vaccination schedule...
View ArticlePrevnar, Pfizer's pneumonia vaccine, okayed for adults in EU
Pfizer's blockbuster vaccine against pneumonia and other bacterial infections has won another approval, for use in European Union residents aged 18 and older.
View ArticlePneumococcal vaccine success in New Zealand children
Infectious disease experts are this week calling New Zealand's pneumococcal vaccination schedule an unequivocal success.
View ArticleVaccinated children: A powerful protection for older adults
Children who receive a vaccine to prevent blood and ear infections, appear to be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults....
View ArticleBrief fever common in kids given influenza, pneumococcal vaccines together
Giving young children the influenza and pneumococcal vaccines together appears to increase their risk of fever, according to a study led by researchers from Columbia University Medical Center (CUMC)...
View ArticleThousands of unvaccinated adults die each year from preventable diseases
While adults make up 95 percent of those who die annually from vaccine preventable diseases, a new study from the University of Colorado School of Medicine shows their vaccination rates remain...
View ArticlePneumococcal conjugate vaccine is effective for preventing community-acquired...
A 10-valent pneumococcal conjugate vaccine (PCV) is effective in reducing the number of new cases of likely-bacterial community-acquired pneumonia in infants in Latin America, according to a study...
View ArticleVaccine against pneumococcal disease halves rates in African children
A vaccine against pneumococcal disease, which is a major killer of children in Africa, has cut the disease rate by more than half, new research has found.
View ArticleNew research asks whether vaccination can prevent heart attacks and strokes...
A major national Monash University collaboration is now testing whether a safe, one-off vaccination can help to reduce the risk of heart attacks and strokes.
View ArticlePatients with coeliac disease should receive pneumonia vaccine
Researchers have found that patients with coeliac disease are at high risk of acquiring pneumonia if they haven't received the pneumococcal vaccine.
View ArticleTwo-minute video boosts pneumonia vaccinations
A simple two-minute video about pneumococcal vaccination sent to patients before a primary care visit tripled the likelihood they would get the vaccine, reports new Northwestern Medicine research. The...
View ArticleGenes that increase children's risk of blood infection identified
A team led by Oxford University has identified genes that make certain children more susceptible to invasive bacterial infections by performing a large genome-wide association study in African children.
View ArticleSuper-vaccine to guard against all strains of pneumococcal disease
A new super-vaccine with the ability to eliminate all 90 known strains of the world's most deadly bacterial disease is being developed.
View ArticleUnvaccinated adults cost the US more than $7 billion a year
Vaccine-preventable diseases among adults cost the U.S. economy $8.95 billion in 2015, and unvaccinated individuals are responsible for 80 percent, or $7.1 billion, of the tab, according to the most...
View ArticleTeam uses Google analytical tool to gauge vaccine effectiveness
Using a statistical method initially developed by Google, a Yale School of Public Health-led research team has devised a novel way to better analyze the impact of vaccines. The research was published...
View ArticleNurses crucial in improving uptake of potentially life-saving vaccine in...
The results of a study presented today at the Annual European Congress of Rheumatology (EULAR) 2017 press conference showed that implementing a vaccination programme run by nursing staff dramatically...
View ArticleTeam publishes longitudinal work on pneumonia
A Marshall University Joan C. Edwards School of Medicine research team has published findings that show patients who recover from invasive pneumococcal pneumonia, on average, live 10 years less when...
View ArticleSingle-dose PCV13 immunogenic, safe in pediatric oncology
(HealthDay)—For pediatric and adolescent oncology patients, a single-dose 13-valent pneumococcal conjugate vaccine (PCV13) is safe and immunogenic, according to a study published online July 11 in Cancer.
View ArticleMany with work-related asthma not getting key vaccine
(HealthDay)—Only half of American adults with work-related asthma get the recommended vaccination against pneumococcal disease, a new study finds.
View ArticlePneumonia vaccine under development provides 'most comprehensive coverage' to...
In 2004, pneumonia killed more than 2 million children worldwide, according to the World Health Organization. By 2015, the number was less than 1 million.
View Article